NLRP3 and tauopathy: Together, these data show that long-term NF-κB/NLRP3-targeting Nanoligomer treatment broadly reduces neuroinflammation, including many cytokines that are directly modulated by NF-κB and NLRP3 [22], and that these changes may contribute to improvements in cognitive function in old wildtype and tauopathy model mice.